HCPCS Level II
G8868
Patients receiving a first course of anti-tnf therapy
- NDC crosswalk
- None in the loaded CMS ASP file
Codes near G8868
These sit next to G8868 in the CMS Level II file. All G codes
- G8863Patients not assessed for risk of bone loss, reason not given
- G8864Pneumococcal vaccine administered or previously received
- G8865Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)
- G8866Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)
- G8867Pneumococcal vaccine not administered or previously received, reason not given
- G8869Patient has documented immunity to hepatitis b and initiating anti-tnf therapy
- G8870Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy
- G8871Patient not receiving a first course of anti-tnf therapy
- G8872Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion
- G8873Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)